{Reference Type}: Case Reports
{Title}: CardioTwins: case report of a transcatheter mitral and tricuspid valve implantation in one patient.
{Author}: Schmidt T;Kuck KH;Marquetand C;Eitel I;Frerker C;
{Journal}: Eur Heart J Case Rep
{Volume}: 8
{Issue}: 7
{Year}: 2024 Jul
暂无{DOI}: 10.1093/ehjcr/ytae336
{Abstract}: <B>UNASSIGNED: </B>Besides transcatheter edge-to-edge repair (TEER), there are new interventional treatment options for mitral and tricuspid regurgitation in evaluation, such as a complete replacement of the valve through a prosthesis.<BR><B>UNASSIGNED: </B>A 78-year-old previous coronary artery bypass graft-operated patient with symptomatic severe mitral regurgitation and tricuspid regurgitation was sequentially treated by a transfemoral transcatheter mitral and tricuspid valve prosthesis (Cardiovalve; Cardiovalve Ltd, Israel) due to unfavourable mitral valve anatomy. The transcatheter mitral valve implantation (TMVI) was performed first and after progression of the tricuspid regurgitation, a second transcatheter valve prosthesis was implanted in tricuspid position (TTVI) 1.5 years later. Imaging showed a twin look-alike picture of a mitral and tricuspid prosthesis and showing the possibility of a complete transcatheter based replacement of the mitral and tricuspid valve.<BR><B>UNASSIGNED: </B>This case shows the possibility of a Cardiovalve prosthesis being used for TMVI and TTVI in a single patient. Especially in TEER ineligible patients, it might be a good treatment option after device approval.